Chemical cytoprotection for stress-free use of human stem cells in basic and translational research

Chemical_cyto_protection
Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term growth and functional differentiation. We recently reported the development of a new small molecule cocktail that can be used as a universal end-to-end solution for stress-free culture of human cells. This four-part small molecule cocktail, which we named CEPT (Chroman 1, Emricasan, trans-ISRIB, Polyamines), enhanced cell survival of genetically stable hPSCs by simultaneously blocking several stress mechanisms that otherwise compromise cell structure and function. CEPT improved routine cell passaging, cryopreservation/thawing of pluripotent and differentiated cells, embryoid body and organoid formation, single-cell cloning, genome editing, and new iPSC line generation. Thus, CEPT represents a unique poly-pharmacological strategy for comprehensive cytoprotection, providing a new rationale for efficient and safe utilization of hPSCs. Conferring cell fitness by multi-target drug combinations may become a common approach in cryobiology, drug development, and regenerative medicine.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Structural heart interventions in aortic valvular disease - IC Core Curriculum 2

esc365

After watching this webinar, participants will understand: current clinical evidence for the percutaneous treatment of structural heart disease; indications for the transcatheter treatment of symptomatic, significant aortic valve stenosis or mitral regurgitation; optimal patient selection for left atrial appendage occlusion; and the recommended training pathways for structural heart disease.
Watch Now

The Immunotherapy Revolution: Towards Future Cancer Treatments

Workcast

The discovery and development of immune checkpoint inhibitors has revolutionized the treatment of certain cancers, with the 2018 Nobel Prize in medicine/physiology recognizing these therapies as a "landmark in our fight against cancer." Yet, despite these advances, putative biomarker identification, efficacy, and drug resistance still pose significant therapeutic challenges. In this webinar, leaders in immuno-oncology — Elaine Mardis (The Ohio State University) and Jedd Wolchok (Memorial Sloan Kettering Cancer Center) — survey the landscape of research, revealing new approaches for harnessing the potential of this transformative therapeutic.
Watch Now

Innovative Technology for Scalable, Plasmid-Free Production

Adeno-associated viral vectors are essential tools for delivering gene therapy to patients and are usually manufactured using plasmid-based approaches. However, there are challenges with working with plasmids on a large scale, including consistency and scalability.
Watch Now

Implementing a real-time PCR-based method for sterility release testing of ATMPs

Currently established rapid methods for sterility testing of advanced therapy medicinal products (ATMPs) are mostly based on growth-based processes or the detection of metabolic activities. However, the requirements for real-time measurement and the testing of cell-containing products cannot be met with most of these methods.
Watch Now

Spotlight

resources